Using high-throughput compound screenings, 5-Aminonaphthalene derivatives have emerged very recently as selective inhibitors of NSD2 activity in multiple myeloma and acute lymphoid leukemia cell lines. Here, NSD2 is linked to plasma cell myeloma.